logo
#

Latest news with #StepanCompany

Stepan to Announce Second Quarter 2025 Results on July 30, 2025
Stepan to Announce Second Quarter 2025 Results on July 30, 2025

Yahoo

time15-07-2025

  • Business
  • Yahoo

Stepan to Announce Second Quarter 2025 Results on July 30, 2025

NORTHBROOK, Ill., July 15, 2025 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its second quarter 2025 earnings results on Wednesday, July 30, 2025 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Luis E. Rojo, President and Chief Executive Officer, and Ruben Velasquez, Vice President and Chief Financial Officer. The call can be accessed by phone and webcast. To access the call by phone, please click on this Registration Link, complete the form and you will be provided with dial in details and a PIN. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time. The webcast can be accessed through the Investors/Conference Calls page at A webcast replay of the conference call will be available at the same location shortly after the call. Corporate Profile Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection products and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries. Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia. The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at More information about Stepan's sustainability program can be found on the Sustainability page at Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guidance," "predict," "potential," "continue," "likely," "will," "would," "should," "illustrative" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by Stepan Company and its management based on their knowledge and understanding of the business and industry, are inherently uncertain. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond Stepan Company's control, that could cause actual results to differ materially from the forward-looking statements contained in this news release. Such risks, uncertainties and other important factors include, among other factors, the risks, uncertainties and factors described in Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and exhibits to those reports, and include (but are not limited to) risks and uncertainties related to accidents, unplanned production shutdowns or disruptions in manufacturing facilities; reduced demand due to customer product reformulations or new technologies; our inability to successfully develop or introduce new products; compliance with laws; our ability to identify suitable acquisition candidates and successfully complete and integrate acquisitions; global competition; volatility of raw material and energy costs and supply; disruptions in transportation or significant changes in transportation costs; downturns in certain industries and general economic downturns; international business risks, including currency exchange rate fluctuations, legal restrictions and taxes; unfavorable resolution of litigation against us; maintaining and protecting intellectual property rights; our ability to access capital markets; global political, military, security or other instability; costs related to expansion or other capital projects; interruption or breaches of information technology systems; our ability to retain executive management and key personnel; and our debt covenants. These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. View original content to download multimedia: SOURCE Stepan Company Sign in to access your portfolio

Stepan (NYSE:SCL) shareholders have endured a 40% loss from investing in the stock three years ago
Stepan (NYSE:SCL) shareholders have endured a 40% loss from investing in the stock three years ago

Yahoo

time12-06-2025

  • Business
  • Yahoo

Stepan (NYSE:SCL) shareholders have endured a 40% loss from investing in the stock three years ago

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But the risk of stock picking is that you will likely buy under-performing companies. We regret to report that long term Stepan Company (NYSE:SCL) shareholders have had that experience, with the share price dropping 44% in three years, versus a market return of about 64%. And more recent buyers are having a tough time too, with a drop of 34% in the last year. Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). During the three years that the share price fell, Stepan's earnings per share (EPS) dropped by 26% each year. This fall in the EPS is worse than the 17% compound annual share price fall. This suggests that the market retains some optimism around long term earnings stability, despite past EPS declines. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. This free interactive report on Stepan's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Stepan, it has a TSR of -40% for the last 3 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence! While the broader market gained around 13% in the last year, Stepan shareholders lost 33% (even including dividends). However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 6% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. It's always interesting to track share price performance over the longer term. But to understand Stepan better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Stepan (at least 1 which is significant) , and understanding them should be part of your investment process. Stepan is not the only stock that insiders are buying. For those who like to find lesser know companies this free list of growing companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Stepan expands AOS output across US facilities
Stepan expands AOS output across US facilities

Fibre2Fashion

time05-06-2025

  • Business
  • Fibre2Fashion

Stepan expands AOS output across US facilities

Stepan Company a global leader in specialty and intermediate chemicals, announced a significant increase in its production capacity for Alpha Olefin Sulfonates (AOS). Through strategic capital investments and process improvements, Stepan has expanded its AOS capacity by 25%. Stepan Company has increased its Alpha Olefin Sulfonates (AOS) production capacity by 25 per cent through capital investments and process upgrades at facilities in Illinois, California, and Georgia. AOS is a versatile, eco-friendly surfactant used in personal care and industrial products. The expansion boosts efficiency, reliability, and Stepan's ability to meet rising demand. With the broadest network of sites and plants producing AOS in North America, Stepan continues to expand its production capacity through strategic initiatives at its Millsdale, Illinois; Anaheim, California; and Winder, Georgia facilities. These efforts included targeted capital investments and process enhancements that have strengthened operational efficiency across multiple locations—delivering increased capacity, greater flexibility, and enhanced reliability for Stepan's customers. "We are excited to announce these enhancements to our AOS production capabilities," said Brandon Suttle, Asset Manager – Sulfonation BM - Product Management. "These improvements not only increase our capacity but also position us to better serve our customers with high-quality AOS products." Stepan's Alpha Olefin Sulfonates are versatile surfactants used in detergents, personal care products, cleaning and industrial applications. Known for their fat-dissolving power, foam stability, and gentle cleansing properties, AOS is ideal for green bathroom cleaners, daily shower cleaners, liquid dishwashing detergents, shampoos, body washes, and facial cleansers. With the rise in demand for sulfate-free products, AOS is a preferred choice for formulators. It offers environmental benefits and produces dense, stable foam, making it appealing for luxurious lather. AOS is also used in Oilfield, Agriculture, Construction, and Emulsion Polymerization industries. Adriano Galimberti, Vice President & Surfactants North America at Stepan, added, "Our commitment to continued improvement and operational excellence has enabled us to prioritize these investments to meet the growing demands of our customers." Stepan continues to explore additional improvements to further expand capacity, develop specialty AOS products, and enhance product quality. Note: The headline, insights, and image of this press release may have been refined by the Fibre2Fashion staff; the rest of the content remains unchanged. Fibre2Fashion News Desk (HU)

At US$48.61, Is It Time To Put Stepan Company (NYSE:SCL) On Your Watch List?
At US$48.61, Is It Time To Put Stepan Company (NYSE:SCL) On Your Watch List?

Yahoo

time25-04-2025

  • Business
  • Yahoo

At US$48.61, Is It Time To Put Stepan Company (NYSE:SCL) On Your Watch List?

Stepan Company (NYSE:SCL), might not be a large cap stock, but it saw significant share price movement during recent months on the NYSE, rising to highs of US$65.59 and falling to the lows of US$45.26. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Stepan's current trading price of US$48.61 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let's take a look at Stepan's outlook and value based on the most recent financial data to see if there are any catalysts for a price change. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. The share price seems sensible at the moment according to our price multiple model, where we compare the company's price-to-earnings ratio to the industry average. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. We find that Stepan's ratio of 21.77x is trading slightly above its industry peers' ratio of 18.19x, which means if you buy Stepan today, you'd be paying a relatively reasonable price for it. And if you believe that Stepan should be trading at this level in the long run, then there should only be a fairly immaterial downside vs other industry peers. Furthermore, Stepan's share price also seems relatively stable compared to the rest of the market, as indicated by its low beta. This may mean it is less likely for the stock to fall lower from natural market volatility, which suggests less opportunities to buy moving forward. Check out our latest analysis for Stepan Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. Stepan's earnings over the next few years are expected to increase by 97%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value. Are you a shareholder? SCL's optimistic future growth appears to have been factored into the current share price, with shares trading around industry price multiples. However, there are also other important factors which we haven't considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at SCL? Will you have enough confidence to invest in the company should the price drop below the industry PE ratio? Are you a potential investor? If you've been keeping an eye on SCL, now may not be the most optimal time to buy, given it is trading around industry price multiples. However, the optimistic forecast is encouraging for SCL, which means it's worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. While conducting our analysis, we found that Stepan has 1 warning sign and it would be unwise to ignore this. If you are no longer interested in Stepan, you can use our free platform to see our list of over 50 other stocks with a high growth potential. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio

Stepan Company (SCL): Among the Low Profile Dividend Champions to Buy
Stepan Company (SCL): Among the Low Profile Dividend Champions to Buy

Yahoo

time18-04-2025

  • Business
  • Yahoo

Stepan Company (SCL): Among the Low Profile Dividend Champions to Buy

We recently published a list of the 15 Low Profile Dividend Champions to Buy. In this article, we are going to take a look at where Stepan Company (NYSE:SCL) stands against other low profile dividend champions. Companies known as Dividend Aristocrats belong to the S&P Index and have raised their dividend payments every year for a minimum of 25 years. On the other hand, Dividend Champions have also maintained at least 25 straight years of dividend growth, though they may not be part of the broader market. It is possible to pursue a strategy that offers both income and growth. Companies that regularly increase their dividends—often referred to as dividend growers—are typically financially sound, well-managed, and of high quality. Over the long term, these businesses not only show lower levels of volatility but also tend to deliver better performance than the broader market, such as the S&P Equal Weight Index. According to a report by Guggenheim, companies that grew and initiated their dividends between May 2005 and December 2024 delivered an annual average return of 10.5%, compared with a 5.5% return of those companies that cut or eliminated their payouts during this period. The broader market produced a 10.4% return on an annual average basis, slightly underperforming the dividend growers. The report also mentioned that dividend growth strategies have generally shown strong performance in both rising and falling markets. For investors, this offers a chance to benefit from long-term market gains while also helping to preserve more value during inevitable market downturns. Dividend-paying stocks provided investors with a degree of stability during the volatile month of March, according to Bank of America, which highlighted several standout names during the market's rough patch. The firm noted that value and dividend-focused stocks performed well that month, as concerns over President Donald Trump's tariff policies unsettled the broader market. The firm's quant strategist, Nigel Tupper, said the following in an April 11 report. 'In March, as global equities fell -4.1% on concerns tariffs could increase and slow growth, the best performing global styles were Value and Dividends,' With investor demand for dividend stocks on the rise, many companies have been steadily increasing their payouts. A report from Janus Henderson revealed that global dividend payments reached an all-time high of $1.75 trillion in 2024, reflecting a 6.6% increase on an underlying basis. The overall headline growth was 5.2%, influenced by fewer one-off special dividends and a stronger US dollar. Out of 49 countries in the index, 17— including major contributors like the US, Canada, France, Japan, and China—set new records for dividend payments. Overall, 88% of companies worldwide either raised their dividends or maintained them throughout the year. Looking ahead, Janus Henderson forecasts that global dividends will rise by 5.0% on a headline basis in the coming year, reaching a new record of $1.83 trillion. Although the stronger US dollar is expected to weigh on headline growth, the underlying growth rate is projected to come in slightly higher, around 5.1%. An industrial complex with its towering smokestacks, showing the scale of the company's specialty chemicals operations. Our Methodology: For this article, we scanned a list of Dividend Champions, which are companies that have raised their payouts for 25 consecutive years or more. From that list, we picked some lesser-known companies with sound financials and strong balance sheets and ranked them according to hedge funds having stakes in them, as per Insider Monkey's database of Q4 2024. At Insider Monkey, we are obsessed with hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). Number of Hedge Fund Holders: 17 Stepan Company (NYSE:SCL) is an Illinois-based company that deals in specialty and intermediate chemicals. The company delivered strong earnings results for fiscal year 2024. Adjusted EBITDA increased by 4% year-over-year, even with the impact of several one-time charges and pre-operating expenses related to its new Pasadena facility. The Surfactants and Specialty Products segments recorded solid double-digit gains in Adjusted EBITDA, though these were partly offset by weaker demand in the Polymers segment. Overall, global sales volume rose by 1%, driven by a 2.5% increase in the Surfactant business, with notable growth momentum seen across several of the company's key strategic markets. Stepan Company (NYSE:SCL) also maintains a solid financial position, supported by strong cash generation. In the fourth quarter, Stepan reported $68.3 million in operating cash flow and $32.1 million in free cash flow. This robust cash flow has allowed the company to raise its dividend for 57 consecutive years, placing it among the best Dividend Champions to invest in. Its quarterly dividend comes in at $0.385 per share for a dividend yield of 3.25%, as of April 17. Overall, SCL ranks 12th on our list of low profile Dividend Champions to invest in. While we acknowledge the potential of SCL as an investment, our conviction lies in the belief that some deeply undervalued dividend stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for a deeply undervalued dividend stock that is more promising than SCL but that trades at 10 times its earnings and grows its earnings at double digit rates annually, check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at .

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store